【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 12
1.2 List of Figures 23
2 Introduction 28
2.1 Catalyst 28
2.2 Related Reports 29
3 Industry Overview 30
3.1 Emergence of Companion Diagnostics 30
3.1.1 Definition of Companion Diagnostics 30
3.1.2 Changing Face of Medicine 31
3.1.3 Definitions of Companion and Personalized Diagnostics 33
3.2 Disease Applications 35
3.2.1 Breast Cancer 35
3.2.2 Colorectal Cancer 38
3.2.3 Melanoma 40
3.2.4 Non-Small Cell Lung Cancer 41
3.3 Companion Diagnostics Technologies 43
3.3.1 Immunochemical Techniques 43
3.3.2 Nucleic Acid Testing 45
3.3.3 Emerging Technologies 52
3.4 Companion Diagnostics Development 54
3.4.1 Economic Value of a Companion Diagnostic 54
3.4.2 When to Develop a Companion Diagnostic Test 55
3.4.3 Strategy 58
3.4.4 Selection of Partner 59
3.4.5 Biomarker Discovery 61
3.5 Clinical Outcomes 62
3.5.1 Role of Companion Diagnostics in Disease Treatment 62
3.5.2 Companion Diagnostic Test Applications 63
3.6 Testing Trends 64
3.6.1 US 64
3.6.2 France 75
3.6.3 Germany 85
3.6.4 Italy 92
3.6.5 Spain 100
3.6.6 UK 106
3.6.7 Japan 120
3.6.8 Brazil 129
3.6.9 China 135
3.6.10 India 143
3.7 Market Access 150
3.7.1 Overview 150
3.7.2 US 150
3.7.3 5EU 154
3.7.4 Japan 165
3.7.5 Brazil 167
3.7.6 China 169
3.7.7 India 172
3.8 Regulatory Issues and Recalls 173
3.8.1 Dako FDA Warning Letter 173
3.8.2 HercepTest Recall 174
3.8.3 Cobas KRAS Test Recall 174
3.8.4 Cobas BRF V600E Test Recall 174
3.8.5 Leica Bond HER2 IHC System 174
3.9 Reimbursement of Companion Diagnostic Tests 175
3.9.1 US 175
3.9.2 Europe 180
3.9.3 APAC 192
3.9.4 South America 197
3.10 M&A, Key Partnerships 199
3.10.1 Significant Mergers and Acquisitions 201
3.10.2 Recent Partnerships 201
3.11 Economic Impact 207
3.11.1 Cost Effectiveness of Companion Diagnostics 207
3.11.2 Cost Effectiveness of Companion Diagnostics: Healthcare Provider Perspective 208
3.12 Market Drivers 214
3.12.1 Driver: Increasing Healthcare Pressures 214
3.12.2 Driver: Adverse Economic Pressures 215
3.12.3 Driver: Availability of New Technologies 215
3.12.4 Driver: FDA Regulatory Changes 216
3.12.5 Driver: Need to Improve Drug Development Processes 216
3.12.6 Driver: Increasing Cancer Incidence 217
3.12.7 Driver: Accelerating Demand for Targeted Therapies 217
3.13 Market Barriers 219
3.13.1 Barrier: Reimbursement Difficulties 219
3.13.2 Barrier: Loss of Indication 219
3.13.3 Barrier: Emergence of Biosimilar Therapies 220
3.13.4 Barrier: Competition with Laboratory-Developed Tests 221
3.13.5 Barrier: Emergence of Next-Generation Gene Sequencing 222
3.13.6 Barrier: Lack of Laboratory Choice in Instrument Selection 223
3.13.7 Barrier: Lack of Patient Awareness about Companion Diagnostic Tests 224
3.13.8 Barrier: Physician Resistance to New Companion Diagnostic Tests 225
4 Competitive Assessment 227
4.1 Overview 227
4.2 Techniques in Use by Currently Marketed Products 227
4.2.1 Immunohistochemistry 227
4.2.2 Fluorescence In Situ Hybridization 227
4.2.3 Polymerase Chain Reaction 228
4.3 Competitive Analysis 228
4.3.1 Breast Cancer Companion Diagnostic Tests 228
4.3.2 Colorectal Cancer Companion Diagnostic Tests 257
4.3.3 Melanoma Companion Diagnostic Tests 267
4.3.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 273
5 Unmet Needs 290
5.1 Need for Improved Cancer Treatments 290
5.2 Need for Objective Tests 290
5.3 Need for High-Throughput Tests 292
5.4 Certainty of Reimbursement 293
5.5 Amount and Type of Tissue Needed for Test 294
5.6 Who Should be Tested? 297
5.7 Test Accuracy 302
5.8 Increasing Test Complexity and Increased Process Failure 305
6 Pipeline Products 306
6.1 Overview 306
6.2 Pipeline by Phase of Development 308
6.3 Pipeline Product Profiles 310
6.3.1 Breast Cancer Companion Diagnostic Tests 310
6.3.2 Colorectal Cancer Companion Diagnostic Tests 318
6.3.3 Melanoma Companion Diagnostic Tests 324
6.3.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 331
7 Clinical Trials to Watch 347
7.1 Overview 347
7.2 Key Clinical Trials Utilizing Pipeline Companion Diagnostic Tests Linked to Specific Drug Therapies 351
8 Current and Future Players 352
8.1 Trends in Corporate Strategy 352
8.1.1 Companion Diagnostics Business Models 352
8.2 Company Profiles 353
8.2.1 Pharmaceutical/Therapy Companies Developing Companion Diagnostic Tests 353
8.2.2 Diagnostics Companies Developing Companion Diagnostic Tests (in Partnership with Pharmaceutical Companies) 409
9 Market Outlooks 492
9.1 By Market Segment 492
9.1.1 Breast Cancer Companion Diagnostic Tests 492
9.1.2 Colorectal Cancer Companion Diagnostic Tests 493
9.1.3 Melanoma Companion Diagnostic Tests 496
9.1.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 498
9.1.5 Technique 504
9.2 By Geography 507
9.2.1 10 Major Markets Overview 507
9.2.2 US 509
9.2.3 France 510
9.2.4 Germany 512
9.2.5 Italy 514
9.2.6 Spain 516
9.2.7 UK 518
9.2.8 Japan 520
9.2.9 Brazil 523
9.2.10 China 525
9.2.11 India 527
10 Appendix 530
10.1 Bibliography 530
10.2 Abbreviations 582
10.3 Report Methodology 584
10.3.1 Coverage 584
10.3.2 Secondary Research 585
10.3.3 Forecasting Methodology 585
10.4 Physicians Included in this Study 587
10.5 About the Authors 589
10.5.1 Andrew Thompson, Ph.D., Senior Analyst, In Vitro Diagnostics 589
10.5.2 Derek Archila, MBA, Lead Analyst, Medical Devices 589
10.5.3 Bonnie Bain, PhD, Global Head of Healthcare 590
10.6 Disclaimer 591
【レポート販売概要】
■ タイトル：腫瘍向けコンパニオン診断：グローバル市場分析と予測■ 英文：MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts
■ 発行日：2014年5月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0189MAR
■ 調査対象地域：グローバル
- 体外受精(IVF)の世界市場予測（～2022年）：画像システム、保育器、キャビネット、精子分離装置、冷凍保存培地、胚培養液The global in vitro fertilization market is projected to reach USD 847.83 Million by 2022 from USD 505.15 Million in 2017, at a CAGR of 10.9%. The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility …
- 入墨除去の世界市場2017-2021About Tattoo RemovalTattoo removal equipment are used to remove tattoos by breaking down the ink in the tattoo. The procedures for tattoo removal include laser, surgical excision, dermabrasion, chemical peel, tattoo removal cream, and intense pulsed light. Technavio’s analysts forecast the global tattoo removal market to grow at a CAGR of 15.85% during the period 2017-2021. [Covered in this report …
- 3D磁気センサーの世界市場展望2017-20276According to Stratistics MRC, the Global 3D Magnetic Sensor Market is expected to grow at a CAGR of 19.7% during the forecast period. Some of the key factors influencing the market are growiing in automotive industry and unceasing growth in consumer electronics. However, Lengthy design phase increases time-to-market and falling average selling prices (ASPS) of sensor components affecting new marke …
- ナノクレイ補強の世界市場分析：用途別（包装、自動車部品、コーティング）、エンドユーザー別（自動車、建設、海洋、電子部品・家電、軍事・防衛）、セグメント予測The global nanoclay reinforcement market is expected to reach USD 4.38 Billion by 2022, according to a new report by Grand View Research, Inc. Nanoclay reinforcement market is expected to witness significant growth over the next seven years owing to a growing need for lightweight, portable, durable, high strength and low cost materials in a wide range of applications including automotive, aerospac …
- Multiple Myeloma (Kahler’s Disease)：グローバル臨床試験レビューH2, 2013Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2013" provides data on the Multiple Myeloma (Kahler’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Multiple Myeloma (Kahler’s Diseas …
- アジアの銀行IT支出市場About banking IT spending Banking enterprises across APEJ have become increasingly dependent on various advanced technologies, and various IT products and services to run their business and drive revenue growth. This trend is expected to intensify, with the role of IT becoming vital and directly contributing to the organization’s agenda. Banks across the globe are adopting IT solutions to optimize …
- 世界のTV及びビデオサービス市場データベース：地上波テレビ、ケーブルテレビ、IPTV、OTTビデオサービス等n/a
- がん分子診断の世界市場：乳がん、大腸がん、前立腺がんAbout oncology molecular diagnostics Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing. Oncology molecular diagnostics is a major application of …
- Negative Pressure Wound Therapy (NPWT) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Negative Pressure Wound Therapy (NPWT) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Negative Pressure Wound Therapy (NPWT) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Negative Pressure Wound Therapy (NPWT) market in the BRICS countries. The report provides value ($m), …
- スマートルームヒーターの世界市場2017-2021About Smart Room Heater Space/room heaters are electric equipment that are used to heat a small area. They are also used as a complementary heat source to the central heating system to facilitate zonal heating and minimize energy costs. Most smart room heaters available in the market are portable, compact, and lightweight. Smart room heaters that feature Wi-Fi connectivity can be remotely operated …
- ユーカリ精油（エッセンシャルオイル）の世界市場2019-2023About this market The demand for natural products is increasing owing to health concerns among consumers. Consumers are interested in being aware about the ingredients in skin care and food and beverage products, and they are showing an increased preference for natural products. This has increased the demand for eucalyptus essential oil. The emergence of several global and regional food manufactur …
- クラウド移行サービスの世界市場予測（～2021年）The cloud migration services market is expected to grow from USD 2.42 Billion in 2016 to USD 7.06 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 23.9% during the forecast period. Rising demand for cloud-based solutions and services, along with the need to lower operational costs and enable quick disaster recovery are the factors driving the market. Cloud integration segment is expecte …
- Babcock & Wilcox Power Generation Group Acquires MEGTEC Systems：M&Aディール分析Babcock & Wilcox Power Generation Group Acquires MEGTEC Systems - Deal Analysis from GlobalData Summary On June 23, 2014, Babcock & Wilcox Power Generation Group (B&W PGG), an equipment manufacturing company, acquired MEGTEC Systems (MEGTEC), an environmental solutions provider, for a purchase consideration of $155m. Following the acquisition, MEGTEC will operate as B&W MEGTEC, a wholly owned subs …
- 米国の地上デジタル放送（DTT）市場About DTT DTT is an advanced and upgraded version of analog TV. DTT offers land-based broadcasting services using radio signals for transmission, eliminating the need for satellites. These signals can be received using antennas and tuners. DTT offers various benefits over analog TV and is the largest free-to-air TV platform. TechNavio's analysts forecast the DTT market in the US to grow at a CAGR …
- 自動車用カーボンセラミックブレーキローターの世界市場2017-2021About Automotive Carbon Ceramic Brake RotorsA ceramic brake rotor is made of ceramic, which is an inorganic solid material. It is very hard yet light, stable, and water resistant. These rotors are one of the superior high-performance braking systems that are commercially available in the market. They help to overcome the drawbacks of iron brake rotors, offering optimum braking performance in sport …
